How is chronic kidney disease (CKD) classified in an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CKD Classification in Adults

Chronic kidney disease must be classified using three dimensions: Cause (C), GFR category (G), and Albuminuria category (A)—the CGA classification system. 1

Diagnostic Criteria

CKD is defined as abnormalities of kidney structure or function present for ≥3 months with implications for health. 1, 2 Either of the following establishes the diagnosis:

  • **GFR <60 mL/min/1.73 m²** (categories G3a-G5) persisting >3 months 3
  • Evidence of kidney damage at any GFR level, most commonly albuminuria with ACR ≥30 mg/g 2, 3

GFR Categories (G)

The classification divides kidney function into six categories based on estimated GFR: 1, 3

  • G1: ≥90 mL/min/1.73 m² (normal or high—requires evidence of kidney damage to diagnose CKD)
  • G2: 60-89 mL/min/1.73 m² (mildly decreased—requires evidence of kidney damage to diagnose CKD)
  • G3a: 45-59 mL/min/1.73 m² (mildly to moderately decreased)
  • G3b: 30-44 mL/min/1.73 m² (moderately to severely decreased)
  • G4: 15-29 mL/min/1.73 m² (severely decreased)
  • G5: <15 mL/min/1.73 m² (kidney failure)

Critical distinction: The subdivision of G3 into G3a and G3b is essential because these categories have markedly different outcomes and risk profiles for mortality, cardiovascular disease, and progression to kidney failure. 1, 3

GFR Estimation Method

  • Use the CKD-EPI equation for calculating creatinine-based eGFR, which has less bias than the MDRD equation, especially at eGFR ≥60 mL/min/1.73 m². 1, 2, 3
  • For patients with eGFR 45-59 mL/min/1.73 m² (G3a) without albuminuria or other kidney damage markers, measure cystatin C to confirm CKD diagnosis, as this group represents 41% of persons estimated to have CKD based on creatinine alone. 1, 2, 3

Albuminuria Categories (A)

Albuminuria severity is classified into three categories using albumin-to-creatinine ratio (ACR): 1, 3

  • A1: <30 mg/g (normal to mildly increased)
  • A2: 30-300 mg/g (moderately increased)
  • A3: >300 mg/g (severely increased)

Important: ACR ≥30 mg/g represents >3 times the normal value and is associated with increased risk for CKD complications. 1 Sex-specific cutoffs of >17 mg/g in men and >25 mg/g in women can also be used. 2

Cause Classification (C)

Assign cause based on: 1

  • Presence or absence of systemic disease (e.g., diabetes, hypertension, autoimmune disease)
  • Location within the kidney of observed or presumed pathologic-anatomic findings (glomerular, tubular, vascular, cystic)

Risk Stratification Using CGA

The combination of GFR and albuminuria categories determines prognosis for adverse outcomes including death, cardiovascular events, and kidney failure: 1

  • Low risk: GFR ≥60 with ACR <30 mg/g
  • Moderate risk: GFR ≥60 with ACR 30-300 mg/g OR GFR 45-59 with ACR <30 mg/g
  • High risk: GFR ≥60 with ACR >300 mg/g OR GFR 45-59 with ACR 30-300 mg/g OR GFR 30-44 with ACR <30 mg/g
  • Very high risk: GFR 45-59 or 30-44 with ACR >300 mg/g OR GFR 30-44 with ACR 30-300 mg/g OR GFR <30 with any albuminuria 1

Common Pitfalls

Avoid diagnosing CKD in patients with eGFR ≥60 mL/min/1.73 m² unless documented markers of kidney damage are present. 2 G1 and G2 categories alone do not fulfill CKD criteria without evidence of structural kidney damage. 1

Do not use creatinine clearance or estimated creatinine clearance, as these overestimate GFR and lead to misclassification. 2

Ensure abnormalities persist for ≥3 months before confirming CKD diagnosis to distinguish chronic from acute kidney disease. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria for Chronic Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chronic Kidney Disease Diagnosis and Staging

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.